Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer

BACKGROUND: Primary cytoreduction followed by platinum based chemotherapy is the primary treatment for advanced ovarian cancer. However neoadjuvant chemotherapy followed by interval debulking is an alternative option, particularly in those who may be poor surgical candidates. OBJECTIVE: The objectiv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Obstet Gynecol
Autors principals: CHAM, Stephanie, CHEN, Ling, ST. CLAIR, Caryn M., HOU, June Y., TERGAS, Ana I., MELAMED, Alexander, ANANTH, Cande V., NEUGUT, Alfred I., HERSHMAN, Dawn L., WRIGHT, Jason D.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545148/
https://ncbi.nlm.nih.gov/pubmed/30771346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2019.02.019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars